Bridgefront Capital’s West Pharmaceutical WST Stock Holding History

Bridgefront Capital’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.6M	Buy	4,449 +1,253	+39%	+$383K	0.42%	55
2026 Q1	$801K	Sell	3,196 -6,152	-66%	-$1.53M	0.2%	166
2025 Q4	$2.57M	Buy	+9,348	New	+$2.56M	0.65%	18
2025 Q3	–	Sell	-1,423	Closed	-$311K	–	861
2025 Q2	$311K	Sell	1,423 -1,856	-57%	-$397K	0.08%	418
2025 Q1	$734K	Buy	+3,279	New	+$904K	0.21%	151
2024 Q1	–	Sell	-571	Closed	-$201K	–	575
2023 Q4	$201K	Sell	571 -61	-10%	-$21.6K	0.15%	299
2023 Q3	$237K	Sell	632 -544	-46%	-$210K	0.17%	275
2023 Q2	$450K	Buy	+1,176	New	+$420K	0.24%	138
2022 Q4	–	Sell	-1,565	Closed	-$385K	–	537
2022 Q3	$385K	Buy	+1,565	New	+$477K	0.39%	81

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Bridgefront Capital's WST Position: Q2 2026 in Review

Bridgefront Capital increased its West Pharmaceutical (WST) stake by 39% in Q2 2026, buying an estimated $383K and bringing the position to 4,449 shares worth $1.6M. The position accounts for 0.42% of the portfolio, ranked #55.

Bridgefront Capital first reported a position in WST in Q3 2022 and has held it in 9 quarters since. The position peaked at $2.57M in Q4 2025. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Bridgefront Capital held 4,449 shares of West Pharmaceutical worth $1.6M as of Q2 2026.
Bridgefront Capital bought 1,253 West Pharmaceutical shares in Q2 2026, an estimated $383K.
West Pharmaceutical made up 0.42% of Bridgefront Capital's portfolio in Q2 2026, its #55 holding.
Bridgefront Capital first reported a position in West Pharmaceutical in Q3 2022 and has held it in 9 quarters since.
Bridgefront Capital's West Pharmaceutical position peaked at $2.57M in Q4 2025.
830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.